Amrize AG (SWX:AMRZ)
| Market Cap | 23.02B |
| Revenue (ttm) | 9.55B +2.5% |
| Net Income | 927.25M -6.1% |
| EPS | 1.68 -3.5% |
| Shares Out | 553.52M |
| PE Ratio | 24.81 |
| Forward PE | 19.20 |
| Dividend | 0.35 (0.83%) |
| Ex-Dividend Date | May 12, 2026 |
| Volume | 793,888 |
| Open | 41.93 |
| Previous Close | 41.53 |
| Day's Range | 41.13 - 42.01 |
| 52-Week Range | 35.20 - 51.34 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 49.60 (+19.26%) |
| Earnings Date | Apr 29, 2026 |
About Amrize AG
Amrize AG engages in the provision of various building solutions for infrastructure, commercial, and residential construction markets in North America. It operates through two segments, Building Materials and Building Envelope. The Building Materials segment offers cement and aggregates, as well as ready-mix concrete, asphalt, and other construction materials. The Building Envelope segment provides advanced roofing and wall systems, including single-ply membranes, insulation, shingles, sheathing, waterproofing, and protective coatings; and adhe... [Read more]
Financial Performance
In 2025, Amrize AG's revenue was $11.82 billion, an increase of 0.95% compared to the previous year's $11.70 billion. Earnings were $1.19 billion, a decrease of -6.99%.
Financial numbers in USD Financial StatementsNews
Insider Buying: Nollaig Forrest Acquires Shares in Amrize Ltd (AMRZ)
Insider Buying: Nollaig Forrest Acquires Shares in Amrize Ltd (AMRZ)
Insider Buying: Roald Brouwer Acquires Additional Shares of Amrize Ltd (AMRZ)
Insider Buying: Roald Brouwer Acquires Additional Shares of Amrize Ltd (AMRZ)
Insider Buying: Stephen Clark Acquires Shares of Amrize Ltd (AMRZ)
Insider Buying: Stephen Clark Acquires Shares of Amrize Ltd (AMRZ)
Amrize price target lowered to $65 from $69 at Morgan Stanley
Morgan Stanley analyst Cedar Ekblom lowered the firm’s price target on Amrize (AMRZ) to $65 from $69 and keeps an Overweight rating on the shares. The firm’s base case implies
Amrize price target lowered to CHF 51 from CHF 53 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Amrize (AMRZ) to CHF 51 from CHF 53 and keeps an Overweight rating on the shares. Published first on TheFly – the
Amrize launches $1B share buyback program
Amrize (AMRZ) will start its previously announced share buyback program on May 6. The program has been authorized for a total of $1B until May 5, 2027, with the shares
Amrize To Begin $1 Bln Share Buyback Program On May 6
(RTTNews) - Amrize Ltd. (AMRZ) a provider of building solutions, on Tuesday announced that it will start its previously announced $1 billion share buyback program on May 6.
Amrize Launches $1 Billion Share Buyback Program
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--Amrize (AMRZ) will start its previously announced share buyback program on May 6, 2026. The program has been authorized for a total of $1 billion USD until...
Amrize price target lowered to $66 from $76 at Citi
Citi analyst Anthony Pettinari lowered the firm’s price target on Amrize (AMRZ) to $66 from $76 and keeps a Buy rating on the shares. Published first on TheFly – the
Amrize price target lowered to $65 from $75 at Truist
Truist lowered the firm’s price target on Amrize (AMRZ) to $65 from $75 and keeps a Buy rating on the shares after its Q1 earnings miss. The Building Envelope segment
Amrize price target lowered to $68 from $70 at Oppenheimer
Oppenheimer lowered the firm’s price target on Amrize (AMRZ) to $68 from $70 and keeps an Outperform rating on the shares following quarterly results. The firm remains encouraged by Amrize’s
Amrize upgraded to Buy from Hold at Vertical Research
Vertical Research upgraded Amrize (AMRZ) to Buy from Hold with an unchanged price target of $70. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news.
Amrize AG Earnings Call Transcript: Q1 2026
Q1 2026 saw 4.7% revenue growth and strong double-digit volume gains in cement and aggregates, offset by softness in building envelope. Guidance for 2026 is reaffirmed, with price increases and operational efficiencies expected to drive margin expansion.
Amrize AG Earnings release: Q1 2026
Amrize AG released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.
Amrize AG Slides: Q1 2026
Amrize AG has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 30, 2026.
Amrize AG Quarterly report: Q1 2026
Amrize AG has published its Q1 2026 quarterly earnings report on April 30, 2026.
Strong Q1 Performance Drives Growth for Amrize (AMRZ)
Strong Q1 Performance Drives Growth for Amrize (AMRZ)
Amrize (AMRZ) Q1 2026: EPS -$0.21 Miss vs. Est. -$0.13, Revenue $2.178B Beat vs. Est. $2. ...
Amrize (AMRZ) Q1 2026: EPS -$0.21 Miss vs. Est. -$0.13, Revenue $2.178B Beat vs. Est. $2.144B -- What Does GF Score 27/100, GF Value N/A Indicate?
Amrize reports Q1 EPS (16c), consensus (14c)
Reports Q1 revenue $2.178B, consensus $2.14B. Jan Jenisch, Chairman and CEO: “I thank our 19,000 Amrize (AMRZ) teammates for delivering 4.7% of revenue growth in the first quarter. While this
Amrize Grows Revenue 4.7% in First Quarter and Reaffirms 2026 Guidance
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--Amrize (AMRZ) announced today its first quarter 2026 financial results. Jan Jenisch, Chairman and CEO: "I thank our 19,000 Amrize teammates for delivering ...
Amrize (AMRZ) Shareholders Endorse Key Proposals at First Annual Meeting
Amrize (AMRZ) Shareholders Endorse Key Proposals at First Annual Meeting
Amrize shareholders approve all proposals at General Meeting
Amrize (AMRZ) shareholders approved all proposals at the company’s first Annual General Meeting on Tuesday. Shareholders approved a special, one-time dividend for 2025 of $0.44 per share to be paid
Amrize Shareholders Approve All Proposals at 2026 Annual General Meeting
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--Amrize (AMRZ) shareholders approved all proposals at the company's first Annual General Meeting today. Shareholders approved a special, one-time dividend f...
Amrize price target raised to CHF 54.80 from CHF 52.43 at JPMorgan
JPMorgan analyst Elodie Rall raised the firm’s price target on Amrize (AMRZ) to CHF 54.80 from CHF 52.43 and keeps an Overweight rating on the shares. Published first on TheFly
Amrize Expands ‘Made in America' Label to Nine U.S. Cement Plants
CHICAGO--(BUSINESS WIRE)--Amrize (NYSE: AMRZ) is expanding its ‘Made in America' label to four additional U.S. plants, now available at 9 plants across the U.S., offering builders the guarantee of Ame...